Development of Quinic Acid-Conjugated Nanoparticles as a Drug Carrier to Solid Tumors
Authors:
- 23 May 2013
- journal article
- research article
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 14 (7) , 2389-2395
Abstract
Nanometer-sized drug carriers including polymeric nanoparticles (NPs) have been used to increase biodistribution of a drug in tumors, thereby reducing the effective dose of chemotherapy. NPs increase drug delivery to tumors to a certain extent, but the amount reaching tumors is only a small fraction of the total administered NPs because they depend on passive accumulation via the leaky vasculature surrounding tumors. In an attempt to further increase the drug delivery to tumors, we develop a polymeric NP system that interacts with an endothelial tumor marker. The NPs are decorated with quinic acid, a synthetic mimic of sialyl Lewis-x, which binds to E-selectin, overexpressed on the surface of endothelial cells surrounding solid tumors. The NPs selectively bind to endothelial cells activated with tumor necrosis factor-α, with weak affinity at a relatively high shear stress. These properties may help NPs reach tumors by increasing the encounter of NPs with the peritumoral endothelium without hindering subsequent transport of the NPs.Keywords
This publication has 63 references indexed in Scilit:
- Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery CarrierPolymers, 2011
- Targeted drug delivery to tumors: Myths, reality and possibilityJournal of Controlled Release, 2011
- Facile Conjugation of Biomolecules onto Surfaces via Mussel Adhesive Protein Inspired CoatingsAdvanced Materials, 2009
- Intracellular Drug Delivery by Poly(lactic-co-glycolic acid) Nanoparticles, RevisitedMolecular Pharmaceutics, 2008
- CD44v4 Is a Major E-Selectin Ligand that Mediates Breast Cancer Cell Transendothelial MigrationPLOS ONE, 2008
- Targeting selectins and selectin ligands in inflammation and cancerExpert Opinion on Therapeutic Targets, 2007
- Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imagingProceedings of the National Academy of Sciences, 2007
- Glycocalyx-mimetic dextran-modified poly(vinyl amine) surfactant coating reduces platelet adhesion on medical-grade polycarbonate surfaceBiomaterials, 2006
- Quinic Acid Derivatives as Sialyl Lewisx-Mimicking Selectin Inhibitors: Design, Synthesis, and Crystal Structure in Complex with E-SelectinJournal of Medicinal Chemistry, 2005
- Sialyl Lewis antigens: association with MUC5AC protein and correlation with post-operative recurrence of non-small cell lung cancerLung Cancer, 2005